Ep140: Yung Lie on Supporting Young Scientists with Bold, Brave Ideas
Ep140: Yung Lie on Supporting Young Scientists with Bold, Brave Ideas
Yung Lie, president and CEO of Damon Runyon Cancer Research Foundation, on advancing cancer research by supporting young... Read more
24 Jul 2023
•
1hr 2mins
Ep139: Kevin Conroy on Early Detection of Cancer
Ep139: Kevin Conroy on Early Detection of Cancer
Kevin Conroy, CEO of Exact Sciences, on early detection of cancer.
10 Jul 2023
•
1hr 8mins
Similar Podcasts
The Readout Loud
BioCentury This Week
First Rounders
Biotech 2050 Podcast
The Bio Report
a16z Podcast
FYI - For Your Innovation
Business Breakdowns
The Knowledge Project with Shane Parrish
Business Of Biotech
The Prof G Pod with Scott Galloway
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
Greymatter
Pivot
HBR IdeaCast
Ep138: Jodie Morrison on Becoming a Biotech CEO
Ep138: Jodie Morrison on Becoming a Biotech CEO
Jodie Morrison, acting CEO of Q32Bio, on becoming a biotech CEO.
27 Jun 2023
•
1hr
Ep137: Aaron Ring on Immunotherapy for Cancer & More
Ep137: Aaron Ring on Immunotherapy for Cancer & More
Aaron Ring, a scientist at Yale moving to the Fred Hutchinson Cancer Center, on applying immunology and protein engineer... Read more
14 Jun 2023
•
56mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Ep136: Deborah Palestrant on Building Biotech Startups
Ep136: Deborah Palestrant on Building Biotech Startups
Deborah Palestrant, partner at 5AM Ventures and head of the 4:59 initiative, on building biotech startups.
30 May 2023
•
52mins
Ep135: John Maraganore on Developing a New Class of Medicines
Ep135: John Maraganore on Developing a New Class of Medicines
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference ... Read more
8 May 2023
•
1hr 3mins
Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies
Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies
Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.
24 Apr 2023
•
1hr 16mins
Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies
Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies
Catherine Stehman-Breen, CEO of Boston-based Chroma Medicine, on developing epigenetic editing therapies.
12 Apr 2023
•
1hr 10mins
Ep132: Eric Dobmeier on Treating Kidney Disease
Ep132: Eric Dobmeier on Treating Kidney Disease
Eric Dobmeier, CEO of Seattle-based Chinook Therapeutics, on new strategies for treating kidney diseases.
28 Mar 2023
•
1hr 5mins
Ep131: Ryan Watts on Neuroscience Drug R&D
Ep131: Ryan Watts on Neuroscience Drug R&D
Ryan Watts, CEO of South San Francisco-based Denali Therapeutics, on neuroscience drug discovery and development.
14 Mar 2023
•
1hr 5mins
